Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Francque

Showing results (151-160 of 177) with videos related to

Pageof 18
Sort By:
Nature Medicine|December 9, 2024
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver diseaseVioleta Raverdy, Federica Tavaglione, Estelle Chatelain, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 30, 2026
ESPGHAN position paper on screening, diagnosis and investigation of paediatric metabolic dysfunction-associated steatotic liver diseaseJake P Mann, Sander Lefere, Maarten Buytaert, et al.
Cell Death and Differentiation|July 26, 2024
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver diseaseCédric Peleman, Stig Hellemans, Geraldine Veeckmans, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 26, 2025
Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of MASLDYasaman Vali, Anne-Marieke van Dijk, Jenny Lee, et al.
The Lancet. Gastroenterology & Hepatology|September 26, 2024
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling studyMathias Jachs, Aitor Odriozola, Fanny Turon, et al.
The New England Journal of Medicine|February 7, 2024
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver FibrosisStephen A Harrison, Pierre Bedossa, Cynthia D Guy, et al.
Contemporary Clinical Trials|October 12, 2020
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver diseaseTimothy Hardy, Kristy Wonders, Ramy Younes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2022
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular CarcinomaMarkus W Löffler, Stefania Gori, Francesco Izzo, et al.
Nature Reviews. Gastroenterology & Hepatology|October 28, 2021
Advancing the global public health agenda for NAFLD: a consensus statementJeffrey V Lazarus, Henry E Mark, Quentin M Anstee, et al.
The Lancet. Gastroenterology & Hepatology|March 23, 2023
Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy studyYasaman Vali, Jenny Lee, Jerome Boursier, et al.
Pageof 18

Showing results (151-160 of 177) with videos related to

Sort By:
Pageof 18
Nature Medicine|December 9, 2024
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver diseaseVioleta Raverdy, Federica Tavaglione, Estelle Chatelain, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 30, 2026
ESPGHAN position paper on screening, diagnosis and investigation of paediatric metabolic dysfunction-associated steatotic liver diseaseJake P Mann, Sander Lefere, Maarten Buytaert, et al.
Cell Death and Differentiation|July 26, 2024
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver diseaseCédric Peleman, Stig Hellemans, Geraldine Veeckmans, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 26, 2025
Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of MASLDYasaman Vali, Anne-Marieke van Dijk, Jenny Lee, et al.
The Lancet. Gastroenterology & Hepatology|September 26, 2024
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling studyMathias Jachs, Aitor Odriozola, Fanny Turon, et al.
The New England Journal of Medicine|February 7, 2024
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver FibrosisStephen A Harrison, Pierre Bedossa, Cynthia D Guy, et al.
Contemporary Clinical Trials|October 12, 2020
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver diseaseTimothy Hardy, Kristy Wonders, Ramy Younes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2022
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular CarcinomaMarkus W Löffler, Stefania Gori, Francesco Izzo, et al.
Nature Reviews. Gastroenterology & Hepatology|October 28, 2021
Advancing the global public health agenda for NAFLD: a consensus statementJeffrey V Lazarus, Henry E Mark, Quentin M Anstee, et al.
The Lancet. Gastroenterology & Hepatology|March 23, 2023
Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy studyYasaman Vali, Jenny Lee, Jerome Boursier, et al.
Pageof 18